Zicha J, Stafová J, Vacek V
Czech Med. 1986;9(4):203-5.
Intravenous infusions of acyclovir were administered to 15 patients suffering from herpes simplex or varicella-zoster infections. The therapeutic effect of the drug consisted in rapid cessation of progression of the disease and in considerable shortening of duration of clinical symptoms. There were no adverse reaction in our groups of patients. There were no relapses after the treatment with acyclovir had been stopped. From what has been stated above, we take acyclovir for a highly efficient and safe drug for therapy of HSV and VZV infections.
对15例患有单纯疱疹或水痘-带状疱疹感染的患者进行了阿昔洛韦静脉输注。该药物的治疗效果在于疾病进展迅速停止以及临床症状持续时间显著缩短。我们的患者组中未出现不良反应。停用阿昔洛韦治疗后未出现复发情况。基于上述情况,我们认为阿昔洛韦是治疗单纯疱疹病毒(HSV)和水痘-带状疱疹病毒(VZV)感染的高效且安全的药物。